Accelerate Diagnostics, Inc: Nasdaq/NYSE listing notice — Nasdaq warns Accelerate Diagnostics of potential delisting due to MVLS below $35M

Accelerate Diagnostics, Inc

Received Nasdaq notice on Jan 28, 2025, for 30 consecutive business days MVLS below $35M minimum.
Company has 180 days (until July 28, 2025) to regain compliance with MVLS requirement.
Regain compliance if MVLS closes at $35M or more for ten consecutive business days before deadline.
Failure to comply may lead to delisting; company can appeal to a Nasdaq Hearing Panel.
Company evaluating actions to regain compliance; no assurance of success.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

January 28, 2025, Accelerate Diagnostics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company t

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

January 28, 2025, Accelerate Diagnostics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (as defined under Nasdaq rules) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C)

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-25-007311

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.